Biology and clinical applications of stem cells for autoimmune and musculoskeletal disorders

Biology and clinical applications of stem cells for autoimmune and musculoskeletal disorders

Edited by Christian Jorgensen and Anthony Hollander

A cross-journal collection in Arthritis Research & Therapy and Stem Cell Research & Therapy.

This series of articles has not been sponsored. All articles have undergone the journal’s standard peer review process overseen by the Series Editors, with final decisions made by the Editors-in-Chief. The Series Editors and Editors-in-Chief declare no competing interests.

1. Content Type:Review

   Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies

   Adult mesenchymal stem cells (MSCs) represent a subject of intense experimental and biomedical interest. Recently, trophic activities of MSCs have become the topic of a number of revealing studies that span bo...

   Authors:Heidi R. Hofer and Rocky S. Tuan

   Citation:Stem Cell Research & Therapy 2016 7:131

   Published on: 9 September 2016

   • ViewFull Text
    
   • ViewPDF
2. Content Type:Review

   Should we use cells, biomaterials, or tissue engineering for cartilage regeneration?

   For a long time, cartilage has been a major focus of the whole field of tissue engineering, both because of the constantly growing need for more effective options for joint repair and the expectation that this...

   Authors:Jonathan C. Bernhard and Gordana Vunjak-Novakovic

   Citation:Stem Cell Research & Therapy 2016 7:56

   Published on: 18 April 2016

   • ViewFull Text
    
   • ViewPDF
3. Content Type:Review

   Update on mesenchymal stem cell-based therapy in lupus and scleroderma

   Current systemic therapies are rarely curative for patients with severe life-threatening forms of autoimmune diseases (ADs). During the past 15 years, autologous hematopoietic stem cell transplantation has bee...

   Authors:Audrey Cras, Dominique Farge, Thierry Carmoi, Jean-Jacques Lataillade, Dan Dan Wang and Lingyun Sun

   Citation:Arthritis Research & Therapy 2015 17:301

   Published on: 3 November 2015

   • ViewFull Text
    
   • ViewPDF
4. Content Type:Review

   Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review

   The evolution of articular cartilage repair procedures has resulted in a variety of cell-based therapies that use both autologous and allogeneic mesenchymal stromal cells (MSCs). As these cells are increasingl...

   Authors:Lucienne A. Vonk, Tommy S. de Windt, Ineke C. M. Slaper-Cortenbach and Daniël B. F. Saris

   Citation:Stem Cell Research & Therapy 2015 6:94

   Published on: 15 May 2015

   • ViewFull Text
    
   • ViewPDF
5. Content Type:Review

   Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?

   The advancements in our understanding of the inflammatory and immune mechanisms in rheumatoid arthritis (RA) have fuelled the development of targeted therapies that block cytokine networks and pathogenic immun...

   Authors:Cosimo De Bari

   Citation:Arthritis Research & Therapy 2015 17:113

   Published on: 1 May 2015

   • ViewFull Text
    
   • ViewPDF
6. Content Type:Review

   Are mesenchymal stromal cells immune cells?

   Mesenchymal stromal cells (MSCs) are considered to be promising agents for the treatment of immunological disease. Although originally identified as precursor cells for mesenchymal lineages, in vitro studies have...

   Authors:Martin J Hoogduijn

   Citation:Arthritis Research & Therapy 2015 17:88

   Published on: 31 March 2015

   • ViewFull Text
    
   • ViewPDF